137 related articles for article (PubMed ID: 1541318)
1. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.
Corder CN; Goldberg MR; Alaupovic PA; Price MD; Furste SS
Eur J Clin Pharmacol; 1992; 42(1):65-70. PubMed ID: 1541318
[TBL] [Abstract][Full Text] [Related]
2. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
Saku K; Ying H; Arakawa K
Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
[TBL] [Abstract][Full Text] [Related]
3. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
[TBL] [Abstract][Full Text] [Related]
4. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories.
Rockhold FW; Goldberg MR; Thompson WL
J Lab Clin Med; 1989 Dec; 114(6):646-54. PubMed ID: 2687423
[TBL] [Abstract][Full Text] [Related]
6. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
7. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
Samuel P
Cor Vasa; 1990; 32(2 Suppl 1):35-41. PubMed ID: 2143459
[TBL] [Abstract][Full Text] [Related]
8. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
9. Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension.
Samuel P; Kirkendall W; Schaefer EJ; Chin B; Schoenfeld BH; Gonasun LM; Lieberman S
Am J Cardiol; 1988 Nov; 62(16):1068-71. PubMed ID: 2973219
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
11. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
12. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
[TBL] [Abstract][Full Text] [Related]
13. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
[TBL] [Abstract][Full Text] [Related]
14. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Scemama M; Février B; Beucler I; Dairou F
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
Lacourcière Y; Arnott W
J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the captopril-hydrochlorothiazide combination on blood lipids. Study in a population of hypertensive hyperlipidemic patients].
Buxtorf JC; Piolot A; Provendier O; Meillard O; Clergeot A; Jacotot B
Presse Med; 1992 Jul 4-11; 21(25):1146-9. PubMed ID: 1409461
[TBL] [Abstract][Full Text] [Related]
17. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
Jones DW; Sands CD
J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
[TBL] [Abstract][Full Text] [Related]
18. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
Spence JD; Huff M; Barnett PA
Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
[TBL] [Abstract][Full Text] [Related]
19. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
[TBL] [Abstract][Full Text] [Related]
20. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
